NANO Nuclear Energy

Nano Nuclear Energy closed the regular session up 5.06% at $17.24, driven by the NRC's formal review initiation of its KRONOS MMR project at the University of Illinois, along with an AI data center deal and a potential UAE dual-listing plan. The stock has rebounded 11.65% from its 52-week low of $15.441 but remains below both the 20-day MA ($19.345) and 60-day MA ($23.568), with a YTD decline of 37.56%. The latest quarter saw net loss narrow 56.92% YoY to $9.18M, and operating income improve 36.42% YoY, though ROE stays negative. However, the CTO's departure and the Russell index removal pose near-term headwinds.

Nano Nuclear Energy opened sharply lower and continued its decline, with intraday losses exceeding 10% at one point, primarily driven by lingering market digestion of its Russell index removal and profit-taking after the earlier AI data center partnership catalyst faded. The stock opened at $17.31, quickly dropped to an intraday low of $16.10—a new 52-week low—and closed at $16.415, down 8.1% from the prior close of $17.87. The company recently received formal NRC review initiation for its KRONOS microreactor project and announced a data center collaboration, but the departure of CTO Heidet has raised concerns about technical execution. The stock has fallen 73% from its 52-week high of $60.87, trades well below its 20-day MA of $20.83 and 60-day MA of $24.02, and is down 40.55% year-to-date. Nonetheless, some analysts view it as a high-risk, high-reward name, suggesting the current valuation already prices in significant headwinds and a policy shift in nuclear energy could offer a recovery opportunity.

NANO Nuclear Energy (NNE.US) fell 5.0% during the regular session, pressured by valuation concerns after its removal from the Russell index and a management shakeup following the termination of CTO Florent Heidet. The stock hit an intraday low of $17.910, retreating about 4.7% from its pre-market high of $18.800, and closed at $17.910, roughly 5.8% below its 52-week high. While the NRC formally accepted the KRONOS microreactor construction permit application, providing a pre-market boost, the session failed to sustain gains. Q2 2026 net loss narrowed 56.92% YoY to $9.18 million, with EPS at -$0.18. The stock trades below MA20 and MA60, with a P/B of 1.57x and market cap of $933 million. Nonetheless, recent developments including a potential Abu Dhabi dual-listing and an AI data center deal could offer a catalyst.

NNE.US experienced a single-day decline, dropping 4.85% to $19.210 as of ET 09:49, hitting an intraday low, primarily as the market shifted focus from the positive news of the NRC's formal review of the KRONOS microreactor to the company's widening losses. Q2 net loss was $9.18 million, improved year-over-year but sequentially wider; EPS of -$0.18 improved 68.68% from a year ago. The stock opened at $19.830 and steadily fell, breaking below both the 20-day MA ($22.855) and 60-day MA ($24.671), trading 68.44% below its 52-week high of $60.87 and down 30.42% year-to-date. However, post-market trading saw a rebound to $20.190, suggesting some buying interest at lower levels.

NNE.US staged a relentless intraday rally, last trading at $21.85 as of ET 09:44, up roughly 5.3% from the prior close of $20.75, driven by a confluence of catalysts: reports of a potential dual-listing and power plant project in Abu Dhabi, the formal start of the NRC's review of its KRONOS microreactor, and the ongoing AI data center demand narrative. The Q2 2026 earnings showed a net loss narrowing 56.92% YoY to $9.18 million, with an EPS of -$0.18 improving 68.68%, though revenue remained nil and operating loss stood at $14.25 million. The stock trades 64.19% below its 52-week high of $60.87, 15.16% above the low of $18.93, and down 21.04% YTD, while also lagging its MA20 ($23.46) and MA60 ($24.77), indicating a weak price position; however, the CTO's departure and persistent commercialization uncertainties act as headwinds.